Unicycive Therapeutics Inc (UNCY)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -22789.474 | -2030.493 | -105.731 | -167.498 | -369.346 |
Return on Equity (%) | 489.819 | 127.37 | -145.037 | -225.471 | 1469.52 |
Return on Invested Capital (%) | 444.118 | 113.643 | -129.979 | -225.396 | 971.883 |
Operating Margin (%) | N/A | N/A | N/A | -1898.212 | -4512.889 |
Net Profit Margin (%) | N/A | N/A | N/A | -1898.843 | -4653.481 |
Book Value Per Share | -0.024 | -0.073 | 1.099 | -0.031 | -0.11 |
Earnings Per Share | -0.06 | -0.062 | -0.668 | -1.197 | -0.904 |
Cash Per Share | N/A | N/A | 1.105 | 0.03 | 0.279 |
Working Capital Per Share | -0.024 | -0.073 | 1.087 | -0.042 | -0.119 |
Operating Profit Per Share | N/A | N/A | N/A | 0.063 | 0.019 |
EBIT Per Share | -0.06 | -0.062 | -0.668 | -1.197 | -0.879 |
EBITDA Per Share | -0.06 | -0.062 | -0.668 | -1.197 | -0.879 |
Free Cash Flow Per Share | -0.06 | -0.062 | -0.666 | -1.197 | -0.904 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 36,36M | 36,61M | 15M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -2157.481 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -2187.704 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 69,58M |
Ratio cours/bénéfice | -2,24 |
Ratio prix/ventes | 103,33 |
Ratio prix/liquidités | 7,24 |
Ratio prix/valeur comptable | -18,45 |
Rendement de dividende | - |
Actions en circulation | 113,32M |
Volume moyen (1 semaine) | 1,42M |
Volume moyen (1 mois) | 1,35M |
Variation sur 52 semaines | -29,02% |
Plus haut sur 52 semaines | 1,818 |
Plus bas sur 52 semaines | 0,202 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales